Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles

Abstract excerpt

MOTIVATION: Somatic homozygous deletions of chromosomal regions in cancer, while not necessarily oncogenic, may lead to therapeutic vulnerabilities specific to cancer cells compared with normal cells. A recently reported example is the loss of one of the two isoenzymes in glioblastoma cancer cells such that the use of a specific inhibitor selectively inhibited growth of the cancer cells, which had become fully...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Bioinformatics and Genomic Networks
• Share to Cancer Genomics and Diagnostics
• Share to Ferroptosis and cancer prognosis